83 related articles for article (PubMed ID: 16598307)
1. Aberrant gene promoter methylation marking disease progression in multiple myeloma.
Chim CS; Liang R; Leung MH; Yip SF; Kwong YL
Leukemia; 2006 Jun; 20(6):1190-2. PubMed ID: 16598307
[No Abstract] [Full Text] [Related]
2. Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.
Du J; Yuan Z; Zhang C; Fu W; Jiang H; Chen B; Hou J
Leuk Res; 2010 Nov; 34(11):1453-8. PubMed ID: 20122728
[TBL] [Abstract][Full Text] [Related]
3. Two cases of plasma cell leukemia with atypical immunophenotype.
Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
[No Abstract] [Full Text] [Related]
4. DNA methylation changes in multiple myeloma.
Galm O; Wilop S; Reichelt J; Jost E; Gehbauer G; Herman JG; Osieka R
Leukemia; 2004 Oct; 18(10):1687-92. PubMed ID: 15318245
[TBL] [Abstract][Full Text] [Related]
5. Infiltration of the spinal cord in a patient with multiple myeloma.
Varettoni M; Corso A; Zappasodi P; Calliada F; Castagnola C; Mangiacavalli S; Lazzarino M
J Clin Oncol; 2008 Sep; 26(25):4207-9. PubMed ID: 18757337
[No Abstract] [Full Text] [Related]
6. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI
Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of the bone morphogenetic protein 6 gene in multiple myeloma.
Hashida Y; Nemoto Y; Imajoh M; Murakami M; Taniguchi A; Komatsu N; Yokoyama A; Daibata M
Oncol Rep; 2012 Mar; 27(3):825-30. PubMed ID: 22086350
[TBL] [Abstract][Full Text] [Related]
8. Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets.
Park G; Kang SH; Lee JH; Suh C; Kim M; Park SM; Kim TY; Oh B; Min HJ; Yoon SS; Yang IC; Cho HI; Lee DS;
Ann Hematol; 2011 Jan; 90(1):73-9. PubMed ID: 20721556
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous presentation and following remission of chronic lymphocytic leukemia and multiple myeloma.
Bernardeschi P; Bonechi I; Marchetti G; Puglisi R
Recenti Prog Med; 1995 Jan; 86(1):25. PubMed ID: 7709037
[No Abstract] [Full Text] [Related]
10. [Myeloma with extramedullary extension coinciding with the normalization of serum paraproteins after treatment].
Bernat S; Gozalbo T; García-Boyero R; Guinot M
Sangre (Barc); 1998 Feb; 43(1):96-7. PubMed ID: 9577192
[No Abstract] [Full Text] [Related]
11. Could DNA methylation become a useful measure for multiple myeloma prognoses?
Walker BA; Morgan GJ
Expert Rev Hematol; 2011 Apr; 4(2):125-7. PubMed ID: 21495920
[No Abstract] [Full Text] [Related]
12. Treatment of multiple myeloma and arterial thrombosis.
Raven W; Berghout A; van Houten A; Leebeek FW
Ann Hematol; 2010 Apr; 89(4):419-20. PubMed ID: 19688212
[No Abstract] [Full Text] [Related]
13. Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib.
Vangsted AJ; Klausen TW; Abildgaard N; Andersen NF; Gimsing P; Gregersen H; Nexø BA; Vogel U
Ann Hematol; 2011 Oct; 90(10):1173-81. PubMed ID: 21347685
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific histone signature and DNA methylation in multiple myeloma and leukemia cells.
Foltankova V; Legartova S; Kozubek S; Bartova E
Neoplasma; 2012; 59(4):450-62. PubMed ID: 22489701
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
[TBL] [Abstract][Full Text] [Related]
16. Familial myeloma. A new observation in two distinct pairs of siblings.
Gobbi PG; Montecucco C; Trespi E; Cavalli C; Gendarini A; Bellotti V; Merlini G; Chèrie-Lignière EL; Ascari E
Haematologica; 1985; 70(4):324-8. PubMed ID: 3935531
[No Abstract] [Full Text] [Related]
17. Multiple myeloma.
Bhattacharya SK; Singh NK; Srivastava PK; Tripathi K; Somani PN
J Indian Med Assoc; 1984 Nov; 82(11):394-7. PubMed ID: 6535796
[No Abstract] [Full Text] [Related]
18. Myelomatous pleural effusion: a diagnostic challenge.
Malhotra KP; Agrawal V; Prasad N
Indian J Cancer; 2010; 47(3):351-2. PubMed ID: 20587921
[No Abstract] [Full Text] [Related]
19. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
Piccinini L; Artusi T; Bonacorsi G; Arigliano V
Haematologica; 2002 Feb; 87(2):EIM04. PubMed ID: 11836178
[No Abstract] [Full Text] [Related]
20. Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines.
Drucker L; Tohami T; Tartakover-Matalon S; Zismanov V; Shapiro H; Radnay J; Lishner M
Carcinogenesis; 2006 Feb; 27(2):197-204. PubMed ID: 16113057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
